Morgan Stanley
-
-
-
-
-
-
-
Regeneron Announces Investor Conference Presentations and Oncology Investor Webcast
-
-
-
-
-
-
-
Regeneron (REGN) named a 'catalyst driven idea' at Morgan Stanley ahead of pivotal data
-
-
-
-
-
-
-
UPDATE: Regeneron Pharma (REGN) PT Raised to $632 but Morgan Stanley Expects Little From Quarterly Results
-
-
-
-
-
-
-
Regeneron Completes Secondary Offering of Common Stock Held by Sanofi
-
-
-
-
-
-
-
Regeneron Pharma (REGN) PT Lowered to $375 at Morgan Stanley
-
-
-
-
-
-
-
Regeneron Pharma (REGN) PT Raised to $409 at Morgan Stanley
-
-
-
-
-
-
-
Regeneron Announces Upcoming Investor Conference Presentations
-
211,042 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

